心房颤动的药物治疗决策 |
| |
引用本文: | 杨延宗. 心房颤动的药物治疗决策[J]. 医学与哲学(人文社会医学版), 2009, 30(3): 20-23 |
| |
作者姓名: | 杨延宗 |
| |
作者单位: | 大连医科大学附属第一医院心内科,辽宁大连116011 |
| |
摘 要: | 对于心房颤动(房颤)必须针对患者的具体情况合理选择好房颤的治疗策略,包括节律控制、频率控制和抗凝治疗。不管哪种策略,药物治疗都是大多数房颤患者的一线方法,需要针对不同的策略选择好和使用好抗心律失常药物,以最大限度地提高疗效和减少副作用。
|
关 键 词: | 心房颤动 抗心律失常药物 治疗策略 |
Strategy on Phamacological Management of Atrial Fibrillation |
| |
Affiliation: | YANG Yan -zong. (the First Affiliated Hospital of Dalian Medical University , Dalian 116011 ,China) |
| |
Abstract: | AF remains the most common and most challenging arrhythmia. There are two basic strategies for the treatment of atrial fibrillation ( AF) : restoration and maintenance of sinus rhythm (rhythm control) and regulation of the ventricular rate during AF ( rate control). The decision how to treat a certain patient should be individualized and depends on the spesific situation including type of AF, on the expected advantages and disadvantages of either strategy. Antiarrhythmic medication should be the first line therapy for each strategy. The choice of the drug must be tailored to the specific characteristics of the given patient to increase the efficacy and decrease the adverse drug effects during the administration of the antiarrhythmic drug. |
| |
Keywords: | atrial fibrillation antiarrhythmic drug therapeutic strategy |
本文献已被 维普 等数据库收录! |